Open
| Close
| High
| Low
| Previous Close
| Daily Price Gain
|
YTD High
| YTD High Date
| YTD Low
| YTD Low Date
| YTD Price Change
| YTD Gain
|
52 Week High
| 52 Week High Date
| 52 Week Low
| 52 Week Low Date
| 52 Week Price Change
| 52 Week Gain
|
These are sample algorithmic trades based on actual market data.
Stock Symbol
| Exchange
| Company URL
| Company Phone
|
CEO
| Headquarters
| Business Address
| |
Sector
| Industry Category
| Industry Group
| CIK
|
About
Prana Biotechnology Ltd. engages in the development of therapies to treat neurodegenerative disease. It includes research and development of treatments for Alzheimer's and Huntington's disease. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Parkville, Australia. | |||
Description
Prana Biotechnology Limited, a development stage company, engages in the research and development of therapeutic drugs in Australia. The company offers PBT-2, a Phase IIa clinical trial product for the treatment of Alzheimer's disease. Its product is designed to treat the underlying causes of degeneration of the brain and the eye as the aging process progresses. The company's product is also applied for other therapies, including age-related cataracts, Huntington disease, Creutzfeldt-Jakob disease, Motor Neuron disease, age-related macular degeneration, cancers, Parkinson's disease, and other neurodegenerative diseases. Prana Biotechnology Limited was founded in 1997 and is based in Parkville, Australia. |